| 000 | 03587naa a22005537i 4500 | ||
|---|---|---|---|
| 001 | UMUN-OA-20261005-AI-049 | ||
| 003 | local | ||
| 005 | 20261005174826.0 | ||
| 006 | m o d | ||
| 007 | cr|||||||||||| | ||
| 008 | 261005s2019 xx o u000 0 eng d | ||
| 024 | 7 |
_a10.1021/acs.chemrev.8b00728 _2doi |
|
| 035 | _a(local)OpenAlex:W2959938226 | ||
| 040 |
_alocal _beng _clocal |
||
| 041 | 0 | _aeng | |
| 100 | 0 |
_aXin Yang _eauthor. |
|
| 245 | 1 | 0 |
_aConcepts of Artificial Intelligence for Computer-Assisted Drug Discovery / _cXin Yang; Yifei Wang; Ryan Byrne [and others]. |
| 264 | 1 |
_a[Place of publication not identified] : _bAmerican Chemical Society, _c2019. |
|
| 300 | _a1 online resource (1 article). | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aPublication type: Review article. | ||
| 500 | _aLinked open-access copy: published version. | ||
| 506 | 0 |
_aOpen access; no subscription required for the linked open-access version. _fUnrestricted online access _2star |
|
| 520 | 3 | _aArtificial intelligence (AI), and, in particular, deep learning as a subcategory of AI, provides opportunities for the discovery and development of innovative drugs. Various machine learning approaches have recently (re)emerged, some of which may be considered instances of domain-specific AI which have been successfully employed for drug discovery and design. This review provides a comprehensive portrayal of these machine learning techniques and of their applications in medicinal chemistry. After introducing the basic principles, alongside some application notes, of the various machine learning algorithms, the current state-of-the art of AI-assisted pharmaceutical discovery is discussed, including applications in structure- and ligand-based virtual screening, de novo drug design, physicochemical and pharmacokinetic property prediction, drug repurposing, and related aspects. Finally, several challenges and limitations of the current methods are summarized, with a view to potential future directions for AI-assisted drug discovery and design. | |
| 540 |
_aCreative Commons Attribution-NonCommercial-NoDerivatives (licence family recorded by the source; version not supplied in metadata). _uhttps://openalex.org/W2959938226 |
||
| 546 | _aIn English. | ||
| 588 | 0 | _aDescription generated from OpenAlex bibliographic metadata retrieved on 5 October 2026; full text linked from the source. | |
| 590 | _aCourse allocation: B. Sc. Artificial Intelligence. | ||
| 650 | 4 | _aartificial intelligence in drug discovery | |
| 650 | 4 | _adeep learning | |
| 650 | 4 | _avirtual screening | |
| 650 | 4 | _aligand-based virtual screening | |
| 650 | 4 | _astructure-based virtual screening | |
| 650 | 4 | _ade novo drug design | |
| 653 | _aB. Sc. Artificial Intelligence | ||
| 653 | _aUMUN open access collection | ||
| 653 | _aartificial intelligence | ||
| 655 | 4 | _aReview articles. | |
| 700 | 0 |
_aYifei Wang _eauthor. |
|
| 700 | 0 |
_aRyan Byrne _eauthor. |
|
| 700 | 0 |
_aGisbert Schneider _eauthor. |
|
| 700 | 0 |
_aShengyong Yang _eauthor. |
|
| 773 | 0 |
_tChemical Reviews _gVol. 119, no. 18, (2019), pages/article 10520-10594 _x0009-2665 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/acs.chemrev.8b00728 _yRead open-access publication _zOpen access. Access and licence reported by the source; this host could not be independently checked by automation. _70 |
| 884 |
_aCourse selection and automated MARC21 enrichment from OpenAlex metadata. _g20261005 _khttps://openalex.org/W2959938226 _qlocal |
||
| 942 | _n0 | ||
| 999 |
_c606 _d606 |
||